16 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockersâ €
Class II
Class I agents ... Channel Blockersâ € Class ... agents in this class ... beta blockers.â € Class ... Channel Blockers Class
Lupus Nephritis Primer
Class I - Minimal Mesangial
Class II - Mesangial Proliferative
Class Ill - Focal Proliferative
Class IV
Lupus Nephritis Primer ... Class I - Minimal ... Mesangial Class ... Nephritis #SLE #Classification ... #diagnosis #management
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table ... #comparison #management
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... #Pharmacology #Management ... #Therapy #Table
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... The classification ... for Fall Risk Assessment ... STEADI) #Diagnosis #Management ... #Fall #Risk #Screening
American Society of Anesthesiologists (ASA) Classification
The ASA classification (Table) aims to predict perioperative mortality rates but
(Table) aims to ... Higher ASA class ... when an ASA class ... compared with an ASA class ... and when an ASA class
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... Algorithm Lifestyle ... • Secondary Causes ... #algorithm #DM2 ... #DMII #Classification
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism - Risk ... PE-related) • PESI class ... Hemodynamics (Stable ... Pulmonary #Embolism #Risk ... prognostication #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... ASA class If ... event, follow ACC algorithm ... the type of and indication ... medical and surgical management
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... : Reduce risk of ... exacerbations Drug Class ... Dosing: 250 mcg tablet ... to reduce the risk